"For more than 40 years, South Denver Gastroenterology has delivered comprehensive, exceptional care providing patients with optimal outcomes for gastrointestinal, pancreatic and liver diseases including colon cancer, Crohn’s disease, ulcerative colitis, gastroesophageal reflux, Hepatitis C and cirrhosis. With clinic locations in Englewood, Lone Tree, Parker and Castle Rock, along with endoscopy centers in Englewood, Lone Tree and Castle Rock, we are committed to improving the health and wellness of our patients."

During the past decade, South Denver Gastroenterology conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 22 clinical trials were completed, i.e. on average, 91.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 12 clinical trials were completed. i.e. 171.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "South Denver Gastroenterology" #1 sponsor was "Gilead Sciences" with 18 trials, followed by "Galapagos NV" with 3 trials sponsored, "Bausch Health Americas, Inc." with 2 trials sponsored, "Genfit" with 2 trials sponsored and "Intercept Pharmaceuticals" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "South Denver Gastroenterology" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "South Denver Gastroenterology" are "Chronic Hepatitis C" (7 trials), "Crohn's Disease" (6 trials), "Nonalcoholic Steatohepatitis" (6 trials), "Ulcerative Colitis" (6 trials) and "Hepatitis C, Chronic" (5 trials). Many other conditions were trialed in "South Denver Gastroenterology" in a lesser frequency.

Most popular intervention types in "South Denver Gastroenterology" are "Drug" (43 trials), "Other" (5 trials), "Biological" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "RBV" (7 trials), "Filgotinib" (4 trials), "Ribavirin" (4 trials) and "PEG" (3 trials). Other intervention names were less common.

The vast majority of trials in "South Denver Gastroenterology" are 48 trials for "All" genders.

Currently, there are NaN active trials in "South Denver Gastroenterology". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 32 completed trials in South Denver Gastroenterology, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in South Denver Gastroenterology, 0 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".

South Denver Gastroenterology has several departments that took part in Clinical trials: "South Denver Gastroenterology - Swedish Medical Center Office" - 4 trials